<SEC-DOCUMENT>0001513162-15-000362.txt : 20150623
<SEC-HEADER>0001513162-15-000362.hdr.sgml : 20150623
<ACCEPTANCE-DATETIME>20150623165113
ACCESSION NUMBER:		0001513162-15-000362
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20150623
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150623
DATE AS OF CHANGE:		20150623

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ITUS Corp
		CENTRAL INDEX KEY:			0000715446
		STANDARD INDUSTRIAL CLASSIFICATION:	PATENT OWNERS & LESSORS [6794]
		IRS NUMBER:				112622630
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-11254
		FILM NUMBER:		15947513

	BUSINESS ADDRESS:	
		STREET 1:		12100 WILSHIRE BOULEVARD
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		31044845200

	MAIL ADDRESS:	
		STREET 1:		12100 WILSHIRE BOULEVARD
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COPYTELE INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<head><title>FORM 8-K</title> </head> <body style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman'; COLOR:#000000; MARGIN-TOP:0px"> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b>UNITED STATES</b></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b>SECURITIES AND EXCHANGE COMMISSION</b></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b>Washington, D.C. 20549</b></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b><u>&nbsp;&nbsp;&nbsp;</u></b></p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b>FORM 8-K</b></p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b>CURRENT REPORT</b></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b>Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934</b></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center>Date of Report (Date of earliest event reported): &nbsp;June 23, 2015</p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b><u>ITUS CORPORATION</u></b></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center>(Exact name of registrant as specified in its charter)</p> <p style=MARGIN:0px align=center><br></p> <table style="FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding=0 cellspacing=0 align=center> <tr> <td width=194 style="PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:4px; MARGIN-TOP:0px; PADDING-RIGHT:4px" valign=top> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b>Delaware</b></p></td> <td width=174 style="PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:4px; MARGIN-TOP:0px; PADDING-RIGHT:4px" valign=top> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b>000-11254</b></p></td> <td width=169 style="PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:4px; MARGIN-TOP:0px; PADDING-RIGHT:4px" valign=top> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b>11-2622630</b></p></td></tr> <tr> <td width=194 style="PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:4px; MARGIN-TOP:0px; PADDING-RIGHT:4px" valign=top> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center>(State or other jurisdictionof incorporation)</p></td> <td width=174 style="PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:4px; MARGIN-TOP:0px; PADDING-RIGHT:4px" valign=top> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center>(CommissionFile Number)</p></td> <td width=169 style="PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:4px; MARGIN-TOP:0px; PADDING-RIGHT:4px" valign=top> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center>(IRS Employer</p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center>Identification No.)</p></td></tr></table> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <table style="FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding=0 cellspacing=0 align=center> <tr> <td width=349 style="PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:4px; MARGIN-TOP:0px; PADDING-RIGHT:4px" valign=bottom> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b>12100 Wilshire Boulevard, Suite 1275</b></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b>Los Angeles, CA</b></p></td> <td width=337 style="PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:4px; MARGIN-TOP:0px; PADDING-RIGHT:4px" valign=bottom> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b>90025</b></p></td></tr> <tr> <td width=349 style="PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:4px; MARGIN-TOP:0px; PADDING-RIGHT:4px"> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center>(Address of principal executive offices)</p></td> <td width=337 style="PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:4px; MARGIN-TOP:0px; PADDING-RIGHT:4px"> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center>(Zip Code)</p></td></tr></table> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center>Registrant<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s telephone number, including area code: &nbsp;<b>(310) 484-5200</b></p> <p style="FONT-SIZE:11pt; MARGIN:0px; TEXT-INDENT:336px">&nbsp;&nbsp;</p> <p style=MARGIN:0px align=center><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center>(Former name or former address, if changed since last report)</p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b><u>&nbsp;&nbsp;&nbsp;</u></b></p> <p style=MARGIN:0px align=center><br></p> <p style="MARGIN-BOTTOM:6px; FONT-SIZE:11pt; MARGIN-TOP:6px" align=justify>Check the appropriate box below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions: </p> <p style="MARGIN-BOTTOM:6px; FONT-SIZE:11pt; PADDING-LEFT:48px; MARGIN-TOP:6px">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17&nbsp;CFR&nbsp;230.425)</p> <p style="MARGIN-BOTTOM:6px; FONT-SIZE:11pt; PADDING-LEFT:48px; MARGIN-TOP:6px">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17&nbsp;CFR&nbsp;240.14a-12)</p> <p style="MARGIN-BOTTOM:6px; FONT-SIZE:11pt; PADDING-LEFT:48px; MARGIN-TOP:6px">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17&nbsp;CFR&nbsp;240.14d-2(b))</p> <p style="MARGIN-BOTTOM:6px; FONT-SIZE:11pt; PADDING-LEFT:48px; MARGIN-TOP:6px">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17&nbsp;CFR&nbsp;240.13e-4(c))</p> <p style=MARGIN:6px><br></p> <p style=MARGIN:0px align=justify><br><br></p> <p style=MARGIN:0px><br></p> <hr size=1> <p style="PAGE-BREAK-BEFORE:always; MARGIN:0px"><br></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:11pt; WIDTH:96px; FLOAT:left; MARGIN-TOP:0px"><font style=BACKGROUND-COLOR:#ffffff><b>Item </font><font style=BACKGROUND-COLOR:#ffffff>7</font><font style=BACKGROUND-COLOR:#ffffff>.0</font><font style=BACKGROUND-COLOR:#ffffff>1</b></font></p> <p style="FONT-SIZE:11pt; PADDING-LEFT:96px; MARGIN:0px; TEXT-INDENT:-2px" align=justify><font style=BACKGROUND-COLOR:#ffffff><b>Regulation FD Disclosure</font><font style=BACKGROUND-COLOR:#ffffff>.</b></font></p> <p style="CLEAR:left; MARGIN:0px" align=justify><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px; TEXT-INDENT:48px" align=justify>On June 23, 2015, ITUS Corporation (the <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#147;</font>Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#148;</font>) issued a press release announcing the formation of a new subsidiary, Anixa Diagnostics Corporation (<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#147;</font>Anixa<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#148;</font>). Anixa<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s mission will be to develop and launch a suite of simple, inexpensive, non-invasive cancer screening tests that can identify asymptomatic patients that have solid-tumors, with minimal numbers of false positives. Anixa will be led by Dr. Amit Kumar, a current director and strategic advisor of the Company, who will become Executive Chairman of Anixa and also assume the role of Vice-Chairman of the Company. A copy of the Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s press release is included herein as Exhibit 99.1</p> <p style=MARGIN:0px align=justify><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px; TEXT-INDENT:48px" align=justify>The Company will hold a web-based conference call on June 24, 2015 at 1:30 p.m. pacific time to present an update on the Company and its new cancer diagnostic initiative, Anixa. The call will be hosted by Robert Berman, the President and Chief Executive Officer of the Company, and Dr. Amit Kumar. To listen and/or participate in the conference call, dial 877-407-0749 for US &amp; Canada, (412-902-0034 for international callers), or login via the web at http://ituscorp.equisolvewebcast.com/cc-6-24, or access the call via the IR Calendar page, which can also be found on ITUS<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font> website, by clicking the <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#147;</font>Investors,<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#148;</font> <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#147;</font>News/Events,<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#148;</font> and <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#147;</font>IR Calendar<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#148;</font> links. &nbsp;A replay of the web-based conference call will be available on the Company<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#146;</font>s website for two weeks.</p> <p style=MARGIN:0px align=justify><br></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:11pt; WIDTH:96px; FLOAT:left; MARGIN-TOP:0px"><b>Item 9.01.</b></p> <p style="FONT-SIZE:11pt; MARGIN:0px; TEXT-INDENT:-2px"><b>Financial Statements and Exhibits.</b></p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:11pt; WIDTH:48px; FLOAT:left; MARGIN-TOP:0px">(d)</p> <p style="FONT-SIZE:11pt; MARGIN:0px; TEXT-INDENT:-2px">Exhibits</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="MARGIN-BOTTOM:-2px; FONT-FAMILY:'Courier New'; WIDTH:48px; FLOAT:left; MARGIN-TOP:0px"><font style=FONT-SIZE:10pt face="Times New Roman">98.1</font></p> <p style="FONT-SIZE:11pt; PADDING-LEFT:48px; MARGIN:0px; TEXT-INDENT:-2px" align=justify>Press release, dated June 23, 2015.</p> <p style="CLEAR:left; MARGIN:0px"><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px"><b>Cautionary Note Regarding Forward-Looking Statements</b></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=justify><font style=BACKGROUND-COLOR:#ffffff>This Current Report, including the exhibits included herein, may contain forward-looking statements. </font><font style=BACKGROUND-COLOR:#ffffff>Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect the Company's current expectations concerning future events and results. We generally use the words <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#147;</font>believes,<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#148;</font> <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#147;</font>expects,<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#148;</font> <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#147;</font>intends,<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#148;</font> <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#147;</font>plans,<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#148;</font> <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#147;</font>anticipates,<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#148;</font> <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#147;</font>likely,<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#148;</font> <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#147;</font>will<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#148;</font> and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#147;</font>Item 1A <font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#150;</font> Risk Factors<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#148;</font> and other sections of our Annual Report on Form 10-K for the fiscal year ended October 31, 2014 as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. </font></p> <p style=MARGIN:0px align=justify><br></p> <p style="MARGIN-BOTTOM:9px; MARGIN-TOP:0px"><br></p> <p style=MARGIN:0px align=center><br><br></p> <p style="FONT-SIZE:8pt; MARGIN:0px">&nbsp;</p> <hr size=1> <p style="PAGE-BREAK-BEFORE:always; MARGIN:0px"><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b>SIGNATURES</b></p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px; TEXT-INDENT:48px">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px">Dated: June 23, 2015</p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:11pt; PADDING-LEFT:336px; MARGIN:0px">ITUS CORPORATION</p> <p style=MARGIN:0px><br></p> <p style="FONT-SIZE:11pt; PADDING-LEFT:336px; MARGIN:0px">By<u>:/s/ Robert A. Berman</u></p> <p style="FONT-SIZE:11pt; PADDING-LEFT:336px; MARGIN:0px">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Robert A. Berman</p> <p style="FONT-SIZE:11pt; PADDING-LEFT:336px; MARGIN:0px">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: President and Chief Executive Officer</p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style="MARGIN-BOTTOM:9px; MARGIN-TOP:0px"><br></p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px align=center><br><br></p> <hr size=1> <p style="PAGE-BREAK-BEFORE:always; MARGIN:0px"><br></p> <p style="FONT-SIZE:11pt; MARGIN:0px" align=center><b>EXHIBIT INDEX</b></p> <p style=MARGIN:0px align=center><br></p> <p style="MARGIN-BOTTOM:-2px; FONT-SIZE:11pt; WIDTH:96px; FLOAT:left; MARGIN-TOP:0px"><u>Exhibit No.</u></p> <p style="FONT-SIZE:11pt; MARGIN:0px; TEXT-INDENT:-2px" align=justify><u>Description</u></p> <table style="FONT-SIZE:10pt; MARGIN-TOP:0px" cellpadding=0 cellspacing=0> <tr style=FONT-SIZE:0px> <td width=72> <td width=576 /> </tr><tr> <td width=72 style="PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN-TOP:0px; PADDING-RIGHT:0px" valign=top> <p style="CLEAR:left; MARGIN:0px"><br></p></td> <td width=576 style="PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN-TOP:0px; PADDING-RIGHT:0px" valign=top> <p style=MARGIN:0px><br></p></td></tr> <tr> <td width=72 height=19 style="PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN-TOP:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:11pt; MARGIN:0px">99.1</p></td> <td width=576 height=19 style="PADDING-BOTTOM:0px; PADDING-TOP:0px; PADDING-LEFT:0px; MARGIN-TOP:0px; PADDING-RIGHT:0px" valign=top> <p style="FONT-SIZE:11pt; MARGIN:0px">Press Release, dated June 23, 2015.</p></td></tr></table> <p style="MARGIN-BOTTOM:10px; MARGIN-TOP:0px">&nbsp;</p> <p style=MARGIN:0px>&nbsp;</p></body>
<!-- EDGAR Validation Code: 7297D334 -->
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<head><title>EXHIBIT 99.1</title> </head> <body style="FONT-SIZE:10pt; FONT-FAMILY:'Times New Roman'; COLOR:#000000; MARGIN-TOP:0px"> <p style="FONT-SIZE:14pt; MARGIN:0px; LINE-HEIGHT:37.5pt" align=right>EXHIBIT 99.1</p> <p style=MARGIN:6px align=center><br></p> <p style="MARGIN-BOTTOM:8px; FONT-SIZE:14pt; MARGIN-TOP:8px" align=center><b>ITUS Announces Formation of Cancer Diagnostics Subsidiary</b></p> <p style="MARGIN-BOTTOM:7px; FONT-SIZE:12pt; MARGIN-TOP:7px" align=justify>LOS ANGELES, CA - June 23, 2015 - ITUS Corporation ("ITUS") OTCQB: ITUS), today announced that it has formed a new subsidiary, Anixa Diagnostics Corporation ("Anixa"), for the purpose of developing and marketing non-invasive, early cancer screening tests. Anixa will be lead by Dr. Amit Kumar, who will become Executive Chairman of Anixa, and also assume the role of Vice-Chairman of ITUS. </p> <p style="MARGIN-BOTTOM:7px; FONT-SIZE:12pt; MARGIN-TOP:7px" align=justify>Robert Berman, ITUS's President and CEO, stated, "Dr. Kumar has many years of experience in cancer diagnostics, is a foremost expert in the utilization of cutting edge technolgies for early cancer screening, and has successfully developed and guided several cancer diagnostic tests through the approval process and to the market. With Dr. Kumar's expertise, together with access to other leading scientists and renowned cancer institutes, we currently have the resources that are necessary to bring non-invasive cancer diagnostic tests to market." </p> <p style="MARGIN-BOTTOM:7px; FONT-SIZE:12pt; MARGIN-TOP:7px" align=justify>Dr. Kumar received his Bachelor's degree in Chemistry from Occidental College, where he graduated with honors. After joint studies at Stanford University, and the California Institute of Technology, Dr. Kumar received his Ph.D. in Chemistry from the California Institute of Technology. He followed his Ph.D. with a post-doctoral fellowship at Harvard University. Dr. Kumar has previously worked as an executive, founder and board member of several biotechnology companies. Most relevant to Anixa, from September 2001 to June 2010, Dr. Kumar was the President and CEO of CombiMatrix Corporation, a company which he took public, and which developed and launched a number of genomic diagnostics tests in multiple areas, including cancer. Since leaving CombiMatrix, Dr. Kumar has been closely evaluating scientific data, and carefully monitoring the advancement of scientific research, in search of technologies that can be used to create highly impactful, cancer screening tests and that are worthy of launching a new company. </p> <p style="MARGIN-BOTTOM:7px; FONT-SIZE:12pt; MARGIN-TOP:7px" align=justify>ANIXA has identified two technologies that it intends to use for its first cancer screening tests. One technology utilizes a biomarker that has been proven to be effective for the early detection of lung cancer, the number one cause of cancer deaths for men and women. The other technology focuses on biomarkers for the early detection of multiple solid tumors at both early and late stages of cancer. Anixa's cancer strategy is based on the premise that the best way to improve the outcomes for cancer patients is early detection, through the utilization of simple, non-invasive, economical screening tests that are highly accurate.</p> <p style=MARGIN:7px align=justify><br><br></p> <hr size=1> <p style="MARGIN-BOTTOM:7px; FONT-SIZE:12pt; PAGE-BREAK-BEFORE:always; MARGIN-TOP:7px" align=justify>On June 24, 2015 at 1:30 PM, ITUS will hold a web-based conference call to present an update on ITUS and its new cancer diagnostic initiative, Anixa. The call will be hosted by Robert Berman and Dr. Amit Kumar. </p> <p style="MARGIN-BOTTOM:7px; FONT-SIZE:12pt; MARGIN-TOP:7px" align=justify>To listen and/or participate in the conference call, dial 877-407-0749 for US &amp; Canada, (412-902-0034 for international callers), or login via the web at http://ituscorp.equisolvewebcast.com/cc-6-24, or access the call via the IR Calendar page, which can also be found on ITUS' website, by clicking the "Investors," "News/Events," and "IR Calendar" links. </p> <p style="MARGIN-BOTTOM:7px; FONT-SIZE:12pt; MARGIN-TOP:7px"><b>About ITUS Corporation</b>ITUS funds, develops, acquires, and licenses emerging technologies such as High-Tech, Biotechnology, Life Sciences, and Informatics. The company has ongoing licensing programs involving encrypted communications, and advanced materials, and an ongoing development program to create highly efficient, flat panel displays, utilizing a proprietary technology for carbon Nanotubes and phosphor luminescence. Additional information is available at www.ITUScorp.com. </p> <p style="MARGIN-BOTTOM:7px; FONT-SIZE:12pt; MARGIN-TOP:7px" align=justify><b>Forward-Looking Statements:</b> Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect ITUS Corporation's current expectations concerning future events and results. We generally use the words "believes," "expects," "intends," "plans," "anticipates," "likely," "will" and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in "Item 1A - Risk Factors" and other sections of our Annual Report on Form 10-K for the fiscal year ended October 31, 2013 as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this press release. </p> <p style="MARGIN-BOTTOM:7px; FONT-SIZE:12pt; MARGIN-TOP:7px" align=justify>ITUS Corporation: FOCUSED ON INNOVATION<font style="FONT-FAMILY:Arial Unicode MS,Times New Roman">&#153;</font></p></body>
<!-- EDGAR Validation Code: 3A1F4F2D -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
